Literature DB >> 11254871

Complementary and alternative medicine in early-stage breast cancer.

M Tagliaferri1, I Cohen, D Tripathy.   

Abstract

Complementary and alternative medicine (CAM) are becoming increasingly popular in many medical situations, particularly among patients with cancer. CAM encompasses a range of modalities including dietary and vitamin supplements, mind-body approaches, acupuncture, and herbal medicines. In contrast to standard chemotherapeutic and hormonal regimens used for the adjuvant treatment of early-stage breast cancer, controlled clinical trials have generated few data on the relationship between CAM and the outcomes of recurrence or survival, or even overall quality of life and safety. The objectives of CAM treatments are manifold: the reduction of toxicities of therapy, improvement in cancer-related symptoms, enhancement of the immune system, and even a direct anticancer effect. The primary basis of CAM rests on empirical evidence and case studies, as well as theoretic physiologic effects. In some cases, laboratory or clinical data lend support to these modalities. Some types of CAM are based on ancient Oriental forms of medicine founded on centuries of experience documented through oral and written text. Nevertheless, the paucity of evidence in the clinical setting limits firm conclusions about the effectiveness or safety of most CAM approaches in breast cancer. This review will summarize the basis for the application of certain CAM modalities in the therapy of early-stage breast cancer and will highlight some of the directions of investigative work that could lead to a rational integration of CAM into conventional adjuvant therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254871     DOI: 10.1016/s0093-7754(01)90049-1

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  20 in total

1.  Can we demonstrate that breast cancer "integrative oncology" is effective? A methodology to evaluate the effectiveness of integrative oncology offered in community clinics.

Authors:  Leanna J Standish; Erin Sweet; Eleonora Naydis; M Robyn Andersen
Journal:  Integr Cancer Ther       Date:  2012-06-27       Impact factor: 3.279

2.  A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer.

Authors:  Neora Yaal-Hahoshen; Yair Maimon; Nava Siegelmann-Danieli; Shahar Lev-Ari; Ilan G Ron; Fani Sperber; Noah Samuels; Jacob Shoham; Ofer Merimsky
Journal:  Oncologist       Date:  2011-06-28

3.  Patients in Northwestern Turkey Prefer Herbs as Complementary Medicine after Breast Cancer Diagnosis.

Authors:  Bahadir M Gulluoglu; Asim Cingi; Tebessum Cakir; Afsar Barlas
Journal:  Breast Care (Basel)       Date:  2008-08-11       Impact factor: 2.860

4.  Prevalence and predictors of complementary therapy use in advanced-stage breast cancer patients.

Authors:  Abigail M Gross; Qin Liu; Susan Bauer-Wu
Journal:  J Oncol Pract       Date:  2007-11       Impact factor: 3.840

5.  Classification of CAM use and its correlates in patients with early-stage breast cancer.

Authors:  Juliann Saquib; Lisa Madlensky; Sheila Kealey; Nazmus Saquib; Loki Natarajan; Vicky A Newman; Ruth E Patterson; John P Pierce
Journal:  Integr Cancer Ther       Date:  2011-03-07       Impact factor: 3.279

6.  Investigation on Semecarpus Lehyam--a Siddha medicine for breast cancer.

Authors:  Srinivasan Sowmyalakshmi; Mohammad Nur-E-Alam; Mohammed A Akbarsha; Subbiah Thirugnanam; Jürgen Rohr; Damodaran Chendil
Journal:  Planta       Date:  2004-10-28       Impact factor: 4.116

7.  Prognosis following the use of complementary and alternative medicine in women diagnosed with breast cancer.

Authors:  Juliann Saquib; Barbara A Parker; Loki Natarajan; Lisa Madlensky; Nazmus Saquib; Ruth E Patterson; Vicky A Newman; John P Pierce
Journal:  Complement Ther Med       Date:  2012-04-27       Impact factor: 2.446

8.  Acupuncture and fatigue: current basis for shared communication between breast cancer survivors and providers.

Authors:  Michael Francis Johnston; Bo Xiao; Ka-Kit Hui
Journal:  J Cancer Surviv       Date:  2007-10-31       Impact factor: 4.442

Review 9.  Complementary and alternative medicine (CAM) and supportive care in cancer: a synopsis of research perspectives and contributions by an interdisciplinary team.

Authors:  Anne Leis; Jennifer Millard
Journal:  Support Care Cancer       Date:  2007-07-17       Impact factor: 3.603

Review 10.  Complications of traditional Chinese/herbal medicines (TCM)--a guide for perplexed oncologists and other cancer caregivers.

Authors:  Joanne Chiu; Thomas Yau; Richard J Epstein
Journal:  Support Care Cancer       Date:  2008-11-14       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.